BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 16191902)

  • 1. Cure of Q fever pneumonia with moxifloxacin: case report.
    Kuzman I; Puljiz I; Ethaković-Rode O
    Scand J Infect Dis; 2005; 37(10):778-80. PubMed ID: 16191902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Q Fever pneumonia: are clarithromycin and moxifloxacin alternative treatments only?
    Morovic M
    Am J Trop Med Hyg; 2005 Nov; 73(5):947-8. PubMed ID: 16282309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacteriostatic and bactericidal activities of moxifloxacin against Coxiella burnetii.
    Rolain JM; Maurin M; Raoult D
    Antimicrob Agents Chemother; 2001 Jan; 45(1):301-2. PubMed ID: 11120982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay.
    Schein J; Janagap-Benson C; Grant R; Sikirica V; Doshi D; Olson W
    Curr Med Res Opin; 2008 Mar; 24(3):895-906. PubMed ID: 18419876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of sequential i.v. to p.o. moxifloxacin versus conventional combination therapies for the treatment of community-acquired pneumonia in patients requiring initial i.v. therapy.
    Katz E; Larsen LS; Fogarty CM; Hamed K; Song J; Choudhri S
    J Emerg Med; 2004 Nov; 27(4):395-405. PubMed ID: 15498622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moxifloxacin monotherapy is effective in hospitalized patients with community-acquired pneumonia: the MOTIV study--a randomized clinical trial.
    Torres A; Garau J; Arvis P; Carlet J; Choudhri S; Kureishi A; Le Berre MA; Lode H; Winter J; Read RC;
    Clin Infect Dis; 2008 May; 46(10):1499-509. PubMed ID: 18419482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Community-Acquired Pneumonia Recovery in the Elderly (CAPRIE): efficacy and safety of moxifloxacin therapy versus that of levofloxacin therapy.
    Anzueto A; Niederman MS; Pearle J; Restrepo MI; Heyder A; Choudhri SH;
    Clin Infect Dis; 2006 Jan; 42(1):73-81. PubMed ID: 16323095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moxifloxacin versus standard therapy in patients with pneumonia hospitalized after failure of preclinical anti-infective treatment.
    Wenisch C; Krause R; Széll M; Laferl H
    Infection; 2006 Aug; 34(4):190-5. PubMed ID: 16896576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of sequential moxifloxacin for treatment of community-acquired pneumonia associated with atypical pathogens.
    Hoeffken G; Talan D; Larsen LS; Peloquin S; Choudhri SH; Haverstock D; Jackson P; Church D
    Eur J Clin Microbiol Infect Dis; 2004 Oct; 23(10):772-5. PubMed ID: 15605184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Q fever community-acquired pneumonia in a patient with Crohn's disease on immunosuppressive therapy.
    Nausheen S; Cunha BA
    Heart Lung; 2007; 36(4):300-3. PubMed ID: 17628200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic fatigue syndrome after Q fever.
    Ledina D; Bradarić N; Milas I; Ivić I; Brncić N; Kuzmicić N
    Med Sci Monit; 2007 Jul; 13(7):CS88-92. PubMed ID: 17599032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute Q fever lobar pneumonia: a case report.
    Tsironi M; Andriopoulos P; Fokas S; Nikokiris G; Mantzourani M; Assimakopoulos G; Aessopos A
    J Infect; 2005 Oct; 51(3):e89-91. PubMed ID: 16230211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Differential diagnostic and therapeutic aspects of Q-fever in a male prisoner. Case report].
    Vanya M; Szili K; Zámolyi S; Magyar H; Kőrösi G; Benkő Á; Hornyák A; Hegedűs Z; György L
    Orv Hetil; 2015 May; 156(18):741-3. PubMed ID: 26042781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Successful treatment of Legionella pneumonia with moxifloxacin in a hemodialysis patient].
    Takakuwa O; Yamamoto T; Kawai A; Torii M; Nakamura A
    Nihon Kokyuki Gakkai Zasshi; 2009 Jul; 47(7):625-30. PubMed ID: 19637806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro susceptibility of Coxiella burnetii to azithromycin, doxycycline, ciprofloxacin and a range of newer fluoroquinolones.
    Lever MS; Bewley KR; Dowsett B; Lloyd G
    Int J Antimicrob Agents; 2004 Aug; 24(2):194-6. PubMed ID: 15288324
    [No Abstract]   [Full Text] [Related]  

  • 16. Evidence-based review of moxifloxacin.
    O'Brien TP
    Int Ophthalmol Clin; 2006; 46(4):61-72. PubMed ID: 17060792
    [No Abstract]   [Full Text] [Related]  

  • 17. Chronic bacterial prostatitis and relapsing Enterococcus faecalis bacteraemia successfully treated with moxifloxacin.
    van Nieuwkoop C; Visser LG; Groeneveld JH; Kuijper EJ
    J Infect; 2008 Feb; 56(2):155-6. PubMed ID: 18083235
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical efficacy of moxifloxacin in the treatment of bacterial keratitis: a randomized clinical trial.
    Constantinou M; Daniell M; Snibson GR; Vu HT; Taylor HR
    Ophthalmology; 2007 Sep; 114(9):1622-9. PubMed ID: 17822972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of Coxiella burnetii pneumonia in an adult].
    Miyashita N; Fukano H; Hara H; Hara F; Nakajima T; Niki Y; Matsushima T
    Nihon Kokyuki Gakkai Zasshi; 2001 Jun; 39(6):446-51. PubMed ID: 11530397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary Nocardia farcinica brain abscess with secondary meningitis and ventriculitis in an immunocompetent patient, successfully treated with moxifloxacin.
    Kandasamy J; Iqbal HJ; Cooke RP; Eldridge PR
    Acta Neurochir (Wien); 2008 May; 150(5):505-6. PubMed ID: 18414775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.